Quotes

Back To Menu

Glaxosmithkline Pharmaceuticals Ltd NSE  /  BSE

Pharmaceuticals, Large Cap

Invest

12 Nov 2018 | 04:15 PM

1,398.10
-22.05 (-1.55%)

  • Outperforms Index

    5.74%

    Return (1Y)

    Beaten Nifty MNC by 7.96%

  • More Volatile

    1.69%

    Standard Deviation (1Y)

    Higher than Nifty MNC by 0.77%

  • Consistent Performer

    7/12

    Months

    beaten Nifty MNC

  • AxisDirect View

    No View

52 Week High-Low

1,800

1,800.05

1,010

1,010.00

News & Announcements

  • Glaxosmithkline Pharmaceuticals standalone net profit declines 22.67% in the September 2018 quarter

    21 days ago

  • GlaxoSmithKline Pharmaceuticals announces board meeting date

    44 days ago

  • Glaxosmithkline Pharmaceuticals fixes record date for bonus issue

    80 days ago

  • Glaxosmithkline Pharmaceuticals standalone net profit rises 235.31% in the June 2018 quarter

    110 days ago

Price vs Volume

Stock Trivia

  • FII shareholding in Glaxosmithkline Pharma Ltd has decreased by -8.51% since past 3 Months

  • FII shareholding in Glaxosmithkline Pharma Ltd has decreased by -17.4% since past 1 Year

  • MF shareholding in Glaxosmithkline Pharma Ltd has increased by 35.47% since past 1 Year

Loading...

Peer Comparison on Risk - Return

Loading...
Loading...